Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
[PMID: 9856404] PubMed record related to this compound for laboratory literature review
It has everything to do with where people are getting it
1,152 adults with obesity/overweight and type 2 diabetes, randomized to retatrutide 4mg, 9mg, 12mg, or placebo over 80 weeks
Retatrutide targets three hormone receptors (GLP-1, GIP, and glucagon), while Ozempic only targets one (GLP-1)
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in improvement of fatty liver index in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: A retrospective nationwide claims database study in Japan
US$ 23.35
US$ 28.78
US$ 29.49
